Detrimental impact of allergic airway disease on live attenuated influenza vaccine

por Roy, Sreeja, Williams, Clare M., Furuya, Yoichi
Publicado 2021

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity

por Roy, Sreeja, Williams, Clare M., Wijesundara, Danushka K., Furuya, Yoichi
Publicado 2020

Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity

por Roy, Sreeja, Williams, Clare M, Pardo, Julian, Wijesundara, Danushka K, Furuya, Yoichi
Publicado 2020

LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza

por Williams, Clare M, Roy, Sreeja, Sun, Wei, Furuya, Andrea M, Wijesundara, Danushka K, Furuya, Yoichi
Publicado 2022

Allergic Airway Disease Prevents Lethal Synergy of Influenza A Virus-Streptococcus pneumoniae Coinfection

por Roberts, Sean, Salmon, Sharon L., Steiner, Donald J., Williams, Clare M., Metzger, Dennis W., Furuya, Yoichi
Publicado 2019

Evaluation of Pneumococcal Surface Protein A as a Vaccine Antigen against Secondary Streptococcus pneumoniae Challenge during Influenza A Infection

por Roberts, Sean, Williams, Clare M., Salmon, Sharon L., Bonin, Jesse L., Metzger, Dennis W., Furuya, Yoichi
Publicado 2019